Ethics. Research. Community.

Fair Game: How Valeant Cashed In Twice on Higher Drug Prices

New York Times. 
[Record Source: New York Times]
It wasn’t just soaring drug prices that helped Valeant Pharmaceuticals’ cash flow. A credit for inventories at those higher prices also plumped the figures.
Access the full text from your libraries at your institution.  You will be navigating away from EthicShare.

Database Keywords

Detailed Record Information

Record TypeNews/Magazine Article
LicenseNone (All rights reserved) ©